Visitors Now:
Total Visits:
Total Stories:
Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Global Influenza Vaccines Market 2016 Share, Trend, Segmentation and Forecast to 2022

Monday, November 21, 2016 3:57
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Description                                      

 

The global influenza vaccines market is anticipated to reach nearly US$ 5 Billion by 2021. Influenza is a highly communicable disease and typically has the most severe impact on children and the elderly. Influenza viruses are considered as a major cause of morbidity and mortality worldwide. The vast population base together with significantly low vaccination coverage in emerging markets, rising government support for immunization and growing awareness of the value of influenza vaccine in preventing disease are the prominent factors that will fuel the growth of the influenza vaccines market.

 

Geographically, North America is the largest market for influenza vaccines capturing around 50% market share in 2015. Asia is the second largest market for influenza vaccines. Europe is the third largest market for influenza vaccines, followed by Latin America with around XX% share in 2015. Australasia accounted for least share of the influenza vaccines market in 2015.

 

Request a sample report @ https://www.wiseguyreports.com/sample-request/756262-global-influenza-vaccines-market-and-trends-analysis

 

On the basis of country, United States captures majority of the influenza vaccines market share. Japan is the second leading market for influenza vaccines with around XX% share in 2015. China and India are the third and fourth leading market for influenza vaccines with XX% and XX% market share respectively in 2015. Brazil, Germany, France, UK, Italy, Spain and South Korea are the other leading market for influenza vaccines.

 

In the influenza vaccines brand sales segment, Sanofi’s Fluzone holds the maximum share of the market being followed by Fluvirin/Flucelvax. GSK’s Fluarix/FluLaval accounts for the third highest share of the influenza vaccines market. FluMist/Fluenz and Afluria/Fluvax stands at the fourth and fifth position in the influenza vaccines market, while Flublok has captured least share of the influenza vaccines market.

The report titled “Global Influenza Vaccines Market and Forecast to 2021 – Size, Share, Growth and Trends Analysis” provides a comprehensive analysis of the fast-evolving influenza vaccines market. This 195 Page report contains 137 Figures and 12 Tables to present a clear picture of the influenza vaccines market landscape.

 

The Influenza Vaccines Market have been analyzed from 5 viewpoints:

1. Influenza Vaccines Market, Persons Vaccinated and Forecast – By Region (2011 – 2021)
2. Influenza Vaccines Market, Persons Vaccinated and Forecast – Country Wise Distribution (2011 – 2021)
3. Global – Influenza Vaccines Brand Sales and Forecast to 2021
4. Global Influenza Vaccines Market – Major Deals
5. Global Influenza Vaccines Market – Driving Factors and Challenges

 

Influenza Vaccines Market, Persons Vaccinated and Forecast – By Region

1. North America
2. Latin America
3. Europe
4. Asia
5. Australasia

 

Influenza Vaccines Market, Persons Vaccinated and Forecast – Country Wise Distribution (25 Countries Covered)

1. United States
2. Canada
3. Brazil
4. Mexico
5. Germany
6. France
7. Italy
8. Spain
9. United Kingdom
10. Netherlands
11. Ireland
12. Denmark
13. Luxembourg
14. Sweden
15. Australia
16. New Zealand
17. Japan
18. China
19. India
20. South Korea
21. Singapore
22. Hong Kong
23. Malaysia
24. Thailand
25. Indonesia

 

Global Influenza Vaccines Brand Sales and Forecast – 7 Brands Analyzed

1. Fluarix/FluLaval
2. Fluzone
3. Fluvirin/Flucelvax
4. Influvac
5. Afluria/Fluvax
6. FluMist/Fluenz
7. Flublok

 

Data Sources

RESEARCHER employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by dedicated team of qualified professionals with deep industry experience and expertise.

Research Methodologies

Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases

 

Complete report details @ https://www.wiseguyreports.com/reports/756262-global-influenza-vaccines-market-and-trends-analysis

 

Table of Contents

 

1. Executive Summary

2. Global – Influenza Vaccines Market Analysis and Forecast (2011 – 2020)

    2.1 Global – Influenza Vaccines Market and Forecast (2011 – 2021)
    2.2 Global – Number of Persons Vaccinated with Influenza Vaccines and Forecast (2011 – 2021)

3. Global – Influenza Vaccines Market Share Analysis and Forecast

    3.1 Influenza Vaccines Market Share and Forecast – Region Wise Analysis (2011 – 2021)
    3.2 Influenza Vaccines Market Share and Forecast – Country Wise Analysis (2011 – 2021)
    3.3 Persons Being Vaccinated with Influenza Vaccines Share and Forecast – Region Wise Analysis (2011 – 2021)
    3.4 Persons Being Vaccinated with Influenza Vaccines Share and Forecast – Country Wise Analysis (2011 – 2021)

4. Influenza Vaccines Market, Persons Vaccinated and Forecast – By Region (2011 – 2021)

    4.1 North America – Influenza Vaccines Market, Persons Vaccinated and Forecast

      4.1.1 North America – Number of Persons Vaccinated with Influenza Vaccines and Forecast
      4.1.2 North America – Influenza Vaccines Market and Forecast

    4.2 Latin America – Influenza Vaccines Market, Persons Vaccinated and Forecast

      4.2.1 Latin America – Number of Persons Vaccinated with Influenza Vaccines and Forecast
      4.2.2 Latin America – Influenza Vaccines Market and Forecast

    4.3 Europe – Influenza Vaccines Market, Persons Vaccinated and Forecast

      4.3.1 Europe – Number of Persons Vaccinated with Influenza Vaccines and Forecast
      4.3.2 Europe – Influenza Vaccines Market and Forecast

    4.4 Asia – Influenza Vaccines Market, Persons Vaccinated and Forecast

      4.4.1 Asia – Number of Persons Vaccinated with Influenza Vaccines and Forecast
      4.4.2 Asia – Influenza Vaccines Market and Forecast

    4.5 Australasia – Influenza Vaccines Market, Persons Vaccinated and Forecast

      4.5.1 Australasia – Number of Persons Vaccinated with Influenza Vaccines and Forecast
      4.5.2 Australasia – Influenza Vaccines Market and Forecast

5. Influenza Vaccines Market, Persons Vaccinated and Forecast – Country Wise Distribution (2011 – 2021)

    5.1 United States – Influenza Vaccines Market, Persons Vaccinated and Forecast

      5.1.1 United States – Number of Persons Vaccinated with Influenza Vaccines and Forecast
      5.1.2 United States – Influenza Vaccines Market and Forecast

    5.2 Canada – Influenza Vaccines Market, Persons Vaccinated and Forecast

      5.2.1 Canada – Number of Persons Vaccinated with Influenza Vaccines and Forecast
      5.2.2 Canada – Influenza Vaccines Market and Forecast

    5.3 Brazil – Influenza Vaccines Market, Persons Vaccinated and Forecast

      5.3.1 Brazil – Number of Persons Vaccinated with Influenza Vaccines and Forecast
      5.3.2 Brazil – Influenza Vaccines Market and Forecast

    5.4 Mexico – Influenza Vaccines Market, Persons Vaccinated and Forecast

      5.4.1 Mexico – Number of Persons Vaccinated with Influenza Vaccines and Forecast
      5.4.2 Mexico – Influenza Vaccines Market and Forecast

    5.5 Germany – Influenza Vaccines Market, Persons Vaccinated and Forecast

      5.5.1 Germany – Number of Persons Vaccinated with Influenza Vaccines and Forecast
      5.5.2 Germany – Influenza Vaccines Market and Forecast

    5.6 France – Influenza Vaccines Market, Persons Vaccinated and Forecast

      5.6.1 France – Number of Persons Vaccinated with Influenza Vaccines and Forecast
      5.6.2 France – Influenza Vaccines Market and Forecast

    5.7 Italy – Influenza Vaccines Market, Persons Vaccinated and Forecast

      5.7.1 Italy – Number of Persons Vaccinated with Influenza Vaccines and Forecast
      5.7.2 Italy – Influenza Vaccines Market and Forecast

    5.8 Spain – Influenza Vaccines Market, Persons Vaccinated and Forecast

      5.8.1 Spain – Number of Persons Vaccinated with Influenza Vaccines and Forecast
      5.8.2 Spain – Influenza Vaccines Market and Forecast

    5.9 United Kingdom – Influenza Vaccines Market, Persons Vaccinated and Forecast

      5.9.1 United Kingdom – Number of Persons Vaccinated with Influenza Vaccines and Forecast
      5.9.2 United Kingdom – Influenza Vaccines Market and Forecast

    5.10 Netherlands – Influenza Vaccines Market, Persons Vaccinated and Forecast

      5.10.1 Netherlands – Number of Persons Vaccinated with Influenza Vaccines and Forecast
      5.10.2 Netherlands – Influenza Vaccines Market and Forecast

    5.11 Ireland – Influenza Vaccines Market, Persons Vaccinated and Forecast

      5.11.1 Ireland – Number of Persons Vaccinated with Influenza Vaccines and Forecast
      5.11.2 Ireland – Influenza Vaccines Market and Forecast

    5.12 Denmark – Influenza Vaccines Market, Persons Vaccinated and Forecast

      5.12.1 Denmark – Number of Persons Vaccinated with Influenza Vaccines and Forecast
      5.12.2 Denmark – Influenza Vaccines Market and Forecast

    5.13 Luxembourg – Influenza Vaccines Market, Persons Vaccinated and Forecast

      5.13.1 Luxembourg – Number of Persons Vaccinated with Influenza Vaccines and Forecast
      5.13.2 Luxembourg – Influenza Vaccines Market and Forecast

    5.14 Sweden – Influenza Vaccines Market, Persons Vaccinated and Forecast

      5.14.1 Sweden – Number of Persons Vaccinated with Influenza Vaccines and Forecast
      5.14.2 Sweden – Influenza Vaccines Market and Forecast

    5.15 Australia – Influenza Vaccines Market, Persons Vaccinated and Forecast

      5.15.1 Australia – Number of Persons Vaccinated with Influenza Vaccines and Forecast
      5.15.2 Australia – Influenza Vaccines Market and Forecast

    5.16 New Zealand – Influenza Vaccines Market, Persons Vaccinated and Forecast

      5.16.1 New Zealand – Number of Persons Vaccinated with Influenza Vaccines and Forecast
      5.16.2 New Zealand – Influenza Vaccines Market and Forecast

    5.17 Japan – Influenza Vaccines Market, Persons Vaccinated and Forecast

      5.17.1 Japan – Number of Persons Vaccinated with Influenza Vaccines and Forecast
      5.17.2 Japan – Influenza Vaccines Market and Forecast

    5.18 China – Influenza Vaccines Market, Persons Vaccinated and Forecast

      5.18.1 China – Number of Persons Vaccinated with Influenza Vaccines and Forecast
      5.18.2 China – Influenza Vaccines Market and Forecast

    5.19 India – Influenza Vaccines Market, Persons Vaccinated and Forecast

      5.19.1 India – Number of Persons Vaccinated with Influenza Vaccines and Forecast
      5.19.2 India – Influenza Vaccines Market and Forecast

    5.20 South Korea – Influenza Vaccines Market, Persons Vaccinated and Forecast

      5.20.1 South Korea – Number of Persons Vaccinated with Influenza Vaccines and Forecast
      5.20.2 South Korea – Influenza Vaccines Market and Forecast

    5.21 Thailand – Influenza Vaccines Market, Persons Vaccinated and Forecast

      5.21.1 Thailand – Number of Persons Vaccinated with Influenza Vaccines and Forecast
      5.21.2 Thailand – Influenza Vaccines Market and Forecast

    5.22 Singapore – Influenza Vaccines Market, Persons Vaccinated and Forecast

      5.22.1 Singapore – Number of Persons Vaccinated with Influenza Vaccines and Forecast
      5.22.2 Singapore – Influenza Vaccines Market and Forecast

    5.23 Hong Kong – Influenza Vaccines Market, Persons Vaccinated and Forecast

      5.23.1 Hong Kong – Number of Persons Vaccinated with Influenza Vaccines and Forecast
      5.23.2 Hong Kong – Influenza Vaccines Market and Forecast

    5.24 Malaysia – Influenza Vaccines Market, Persons Vaccinated and Forecast

      5.24.1 Malaysia – Number of Persons Vaccinated with Influenza Vaccines and Forecast
      5.24.2 Malaysia – Influenza Vaccines Market and Forecast

    5.25 Indonesia – Influenza Vaccines Market, Persons Vaccinated and Forecast

      5.25.1 Indonesia – Number of Persons Vaccinated with Influenza Vaccines and Forecast
      5.25.2 Indonesia – Influenza Vaccines Market and Forecast

6. Global – Influenza Vaccines Brand Sales and Forecast

    6.1 Global – Fluarix / FluLaval Sales and Forecast (2007 – 2021)
    6.2 Global – Fluzone Sales and Forecast (2009 – 2021)
    6.3 Global – Fluvirin/Flucelvax Sales and Forecast (2010 – 2021)
    6.4 Global – Influvac (Acquired by Abbott) Sales (2007 – 2009)
    6.5 Global – Afluria/Fluvax Sales and Forecast (2010 – 2021)
    6.6 Global – FluMist/Fluenz Sales and Forecast (2007 – 2021)
    6.7 Global – Flublok Sales and Forecast (2013 – 2021)

7. Influenza Vaccines Market – Major Deals

    7.1 Mergers and Acquisitions
    7.2 Licensing Agreements

8. Global Influenza Vaccines Market – Driving Factors

    8.1 Transformation of Vaccine Technologies
    8.2 Vaccines most Cost Effective Means of Disease Prevention
    8.3 Scientific & Technological Breakthroughs
    8.4 Continuous Focus on Effective Communication Strategies
    8.5 Increasing Awareness on Seasonal Influenza & Vaccination

9. Global Influenza Vaccines Market – Challenges

    9.1 Complexity of Vaccine Development and Approval System Thwarts Product Development

      9.1.1 Legal Obstacles
      9.1.2 General Technical BarriersError! Bookmark not defined.
      9.1.3 Economic Barriers
      9.1.4 Regulatory Barriers

    9.2 Hurdles to Optimal use of Licensed Vaccines

      9.2.1 Technical Obstacles
      9.2.2 Economic obstacles
      9.2.3 Cultural Obstacles

    9.3 Barriers to New Entrants in the Vaccines Market
    9.4 Reducing the Timeline for Vaccine Development
    9.5 Challenges Faced by Healthcare Workers in Immunization

Continued…

 

Buy this report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=756262

 

Contact US:

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.